Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$603.18
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Jul 23, 2026 | $5.71 | $6.03 | Beat +5.6% | $4.68 | $11.7B | $12.0B | +2.6% | 1D Pre+0.6% | On-Day+8.7% | 1D Post-0.7% |
Q ended Mar 31, 2026 Reported Apr 23, 2026 | $5.24 | $5.44 | Beat +3.8% | $4.43 | $10.9B | $11.0B | +0.9% | 1D Pre-2.0% | On-Day-9.2% | 1D Post+0.6% |
Q ended Dec 31, 2025 Reported Jan 29, 2026 | $6.45 | $6.57 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| $11.9B |
| $12.2B |
| +2.5% |
| 1D Pre-2.5% |
| On-Day-2.6% |
| 1D Post-2.3% |
Q ended Sep 30, 2025 Reported Oct 22, 2025 | $5.50 | $5.79 | Beat +5.3% | — | $10.9B | $11.1B | +1.8% | 1D Pre+2.6% | On-Day+1.7% | 1D Post+0.8% |